2023 HIV Treatment and Prevention Agents Vaccines 
Pharmacy Times
JULY 16, 2025
Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. Zanubrutinib demonstrated sustained efficacy in CLL with del(17p), emphasizing the importance of BTK inhibitors in high-risk hematologic malignancies.
Pharmacy Times
JULY 25, 2025
In 2023, 38.9 SHOW MORE Cephalosporins are commonly prescribed in the outpatient setting; understanding differences among them is important for pharmacists. Image credit: ridvanarda | stock.adobe.com In the United States, cephalosporins are one of the most commonly prescribed classes of antibiotics in the outpatient setting.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 8, 2025
GLP-1 receptor agonists should be considered as second-line agents for older adults with DKD, but potential gastrointestinal side effects must be monitored. SHOW MORE Pharmacists should consider GLP-1 receptor agonists as second-line agents in older adults with DKD when additional glycemic control is needed.
Pharmacy Times
JULY 18, 2025
Safe disposal options include DEA Take Back Days, pharmacy kiosks, law enforcement kiosks, mail-back envelopes, and home disposal methods.
Pharmacy Times
JULY 24, 2025
Finerenone, a nonsteroidal MRA, shows promise in reducing HF events and atrial fibrillation, offering potential benefits over steroidal MRAs like spironolactone. Barriers to finerenone integration include cost, access, and existing MRA underutilization, with pharmacists crucial in educating prescribers and patients.
Pharmacy Times
AUGUST 8, 2025
Insulin absorption varies between cognitively normal individuals and those with mild cognitive impairment, with higher uptake in the former. The study validates the nasal delivery system's effectiveness, crucial for designing successful therapeutic trials for Alzheimer’s disease.
Pharmacy Times
JULY 19, 2025
Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. Jansen, PharmD Candidate , Mark A.
Expert insights. Personalized for you.
Let's personalize your content